CDK9-IN-2
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-16462-5MG | 5 mg | 317,00 | Add | |
| HY-16462-1ML | 10mM/1mL | 348,00 | Add | |
| HY-16462-10MG | 10 mg | 469,00 | Add | |
| HY-16462-50MG | 50 mg | 1'230,00 | Add | |
| HY-16462-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, extracted from patent WO/2012131594A1, compound CDKI(8), has an IC50 of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (72 hours), respectively.
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Cell Cycle/DNA Damage |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.37% |
| Molecular Formula | C23H25ClFN5 |
| Molecular Weight | 425.93 |
| CAS-Number | 1263369-28-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
